Literature DB >> 9769334

Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.

E Allaire1, R Forough, M Clowes, B Starcher, A W Clowes.   

Abstract

Although matrix metalloproteinases (MMPs) are expressed in abundance in arterial aneurysms, their contribution to arterial wall degeneration, dilation, and rupture has not been determined. We investigated MMP function in a rat model of aneurysm associated with arterial dilation, elastin loss, medial invasion by mononuclear inflammatory cells, and MMP upregulation. Rupture was correlated with increased gelatinase B (MMP-9) and activated gelatinase A (MMP-2). Syngeneic rat smooth muscle cells retrovirally transfected with tissue inhibitor of matrix metalloproteinases (TIMP)-1 cDNA (LTSN) or with the vector alone as a control (LXSN) were seeded onto the luminal surface of the vessels. The seeding of LTSN cells resulted in TIMP-1 local overexpression. The seeding with LTSN cells, but not LXSN cells, decreased MMP-9, activated MMP-2 and 28-kD caseinase and elastase activity, preserved elastin in the media, and prevented aneurysmal degeneration and rupture. We conclude that MMP overexpression is responsible for aneurysmal degeneration and rupture in this rat model and that local pharmacological blockade might be a reasonable strategy for controlling the formation of aneurysms in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769334      PMCID: PMC508989          DOI: 10.1172/JCI2909

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

2.  Cloning and characterization of a cDNA encoding the baboon tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).

Authors:  R Forough; S T Nikkari; D Hasenstab; H Lea; A W Clowes
Journal:  Gene       Date:  1995-10-03       Impact factor: 3.688

3.  Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin.

Authors:  S Katsuda; Y Okada; Y Okada; K Imai; I Nakanishi
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism.

Authors:  M L Corcoran; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

5.  Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.

Authors:  L Chesler; D W Golde; N Bersch; M D Johnson
Journal:  Blood       Date:  1995-12-15       Impact factor: 22.113

6.  Features of autoimmunity in the abdominal aortic aneurysm.

Authors:  A K Gregory; N X Yin; J Capella; S Xia; K M Newman; M D Tilson
Journal:  Arch Surg       Date:  1996-01

7.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Characterization of rat uterine matrilysin and its cDNA. Relationship to human pump-1 and activation of procollagenases.

Authors:  S R Abramson; G E Conner; H Nagase; I Neuhaus; J F Woessner
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

9.  Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.

Authors:  D Petrinec; S Liao; D R Holmes; J M Reilly; W C Parks; R W Thompson
Journal:  J Vasc Surg       Date:  1996-02       Impact factor: 4.268

10.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.

Authors:  T Freestone; R J Turner; A Coady; D J Higman; R M Greenhalgh; J T Powell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more
  59 in total

Review 1.  The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies.

Authors:  A Luttun; M Dewerchin; D Collen; P Carmeliet
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

2.  Proteinases in cardiovascular aneurysms and rupture: targets for therapy?

Authors:  P Carmeliet
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Angiotensin II, atherosclerosis, and aortic aneurysms.

Authors:  B C Berk; J Haendeler; J Sottile
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 4.  Who are the proteolytic culprits in vascular disease?

Authors:  W C Parks
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.

Authors:  Karina M Mata; Paula S Prudente; Fabio S Rocha; Cibele M Prado; Elaine M Floriano; Jorge Elias; Elen Rizzi; Raquel F Gerlach; Marcos A Rossi; Simone G Ramos
Journal:  Int J Exp Pathol       Date:  2010-10-29       Impact factor: 1.925

Review 6.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

7.  Can local secretion of prostaglandin E2, thromboxane B2, and interleukin-6 play a role in ruptured abdominal aortic aneurysm?

Authors:  Bernice L Y Cheuk; Stephen W K Cheng
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

8.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

9.  Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis.

Authors:  Eric Allaire; Béatrice Muscatelli-Groux; Anne-Marie Guinault; Carine Pages; Audrey Goussard; Chantal Mandet; Patrick Bruneval; Didier Méllière; Jean-Pierre Becquemin
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

10.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.